Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

almirall s.a - dimetüülfumaraat - psoriaas - immunosupressandid - sidumisvastased ravimid on näidustatud mõõduka kuni raskekujulise naastulise psoriaasi ravis täiskasvanutel, kes vajavad süsteemset meditsiinilist ravi.

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

accord healthcare s.l.u. - dimetüülfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosupressandid - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

teva gmbh - dimetüülfumaraat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosupressandid - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

mylan ireland limited - dimetüülfumaraat - sclerosis multiplex, relapsing-remitting - immunosupressandid - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Liên Minh Châu Âu - Tiếng Estonia - EMA (European Medicines Agency)

biogen netherlands b.v. - dimetüülfumaraat - hulgiskleroos - immunosupressandid - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Estonia - Tiếng Estonia - Ravimiamet

zentiva k.s. - dimetüülfumaraat - gastroresistentne kõvakapsel - 120mg 14tk

Estonia - Tiếng Estonia - Ravimiamet

zentiva k.s. - dimetüülfumaraat - gastroresistentne kõvakapsel - 240mg 56tk

Estonia - Tiếng Estonia - Ravimiamet

sandoz pharmaceuticals d.d. - dimetüülfumaraat - gastroresistentne kõvakapsel - 120mg 14tk